Skip to content

Debt-to-assets at other companies

Eli Lilly logo
Eli LillyLLY
0.4×-0.1×
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-0.1×
Monopar Therapeutics logo
Monopar TherapeuticsMNPR
0.0×
Immunome logo
ImmunomeIMNM
0.0×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
0.0×
Lantheus Holdings logo
Lantheus HoldingsLNTH
0.3×0.0×

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp
FCF margin-1,073.3%

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0.0×
Current ratio8.7×-8.3×

Where this comes from

Calculated from Perspective Therapeutics’s reported figures.

Based on the most recent quarter.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perspective Therapeutics's debt-to-assets?
Perspective Therapeutics (CATX) reported debt-to-assets of 0× in Q1 2026.
How has Perspective Therapeutics's debt-to-assets changed year-over-year?
Perspective Therapeutics's debt-to-assets decreased by 10.5% year-over-year, from 0× to 0×.
What is the long-term trend for Perspective Therapeutics's debt-to-assets?
Over 4 years (2020 to 2025), Perspective Therapeutics's debt-to-assets has grown at a -32.5% compound annual growth rate (CAGR), from 0.1× to 0×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.